Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update
Abstract The Epstein–Barr virus (EBV) is a DNA lymphotropic herpesvirus and the causative agent of infectious mononucleosis. EBV is highly prevalent since it affects more than 90% of individuals worldwide and has been linked to several malignancies including PTLDs, which are one of the most common malignancies following transplantation. Among all the EBV genes, most of the recent investigations f
Abstract The Epstein–Barr virus (EBV) is a DNA lymphotropic herpesvirus and the causative agent of infectious mononucleosis. EBV is highly prevalent since it affects more than 90% of individuals worldwide and has been linked to several malignancies including PTLDs, which are one of the most common malignancies following transplantation. Among all the EBV genes, most of the recent investigations focused on studying the LMP-1 oncogene because of its high degree of polymorphism and association with tumorigenic activity. There are two main EBV genotypes, Type 1 and 2, distinguished by the…
related reading
- Frontiers | Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Updatefrontiersin.org
- Clinical manifestations and treatment of Epstein-Barr virus infectionuptodate.com
- HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection - PMCncbi.nlm.nih.gov
- HIV-related lymphomas: Primary central nervous system lymphomauptodate.com
- HIV-related lymphomas: Primary central nervous system lymphomauptodate.com
- Infectious mononucleosis - UpToDateuptodate.com
- Infectious mononucleosis - UpToDateuptodate.com
- Herpetic Gingivostomatitis - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer - PMCncbi.nlm.nih.gov
- Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer - PubMedpubmed.ncbi.nlm.nih.gov
- CG-dinucleotide suppression enables antiviral defense targeting non-self RNA - PMCncbi.nlm.nih.gov
- Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children - PubMedpubmed.ncbi.nlm.nih.gov